title: Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.
abstract: The study examined associations between Hepatitis C (HCV) seropositivity and a lifetime history of jail or correctional facility incarceration among injection drug users. The sample consisted of 351 injection drug users recruited in inner-city neighborhoods of Baltimore. Multiple logistic regressions were fit to assess associations between HCV seropositivity and a lifetime history of incarceration for the total sample and stratified by race. Analyses demonstrated HCV nearly two times greater for whites than African Americans. In addition, HCV was 2.6 times greater in participants incarcerated in correctional facilities and HCV was 7.4 times greater in participants reporting more than 5 years of injection drug use compared to participants reporting less than 1 year of injection drug use. The study findings suggest that incorporating systematic HCV screening, prevention, and treatment programs within correctional systems represents a vital yet underutilized strategy to reduce HCV transmission in society as a whole.
authors.affiliation: The Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
authors.forename: William W
authors.initials: WW
authors.lastname: Latimer
authors.forename: Sarra L
authors.initials: SL
authors.lastname: Hedden
authors.forename: Leah
authors.initials: L
authors.lastname: Floyd
authors.forename: April
authors.initials: A
authors.lastname: Lawson
authors.forename: Alexander
authors.initials: A
authors.lastname: Melnikov
authors.forename: S Geoffrey
authors.initials: SG
authors.lastname: Severtson
authors.forename: Anne-Gloria
authors.initials: AG
authors.lastname: Moleko
authors.forename: Kristin
authors.initials: K
authors.lastname: Cole
references.citation: Public Health. 2003 Jan;117(1):43-8
references.pmid: 12802904
references.citation: Liver. 1995 Aug;15(4):209-12
references.pmid: 8544644
references.citation: J Clin Microbiol. 1997 Dec;35(12):3274-7
references.pmid: 9399533
references.citation: Am J Public Health. 2004 Jul;94(7):1218-23
references.pmid: 15226146
references.citation: Gastroenterol Clin North Am. 1994 Sep;23(3):437-55
references.pmid: 7989088
references.citation: Curr Gastroenterol Rep. 2004 Feb;6(1):66-70
references.pmid: 14720456
references.citation: Hepatology. 2000 Mar;31(3):756-62
references.pmid: 10706569
references.citation: Int J Drug Policy. 2007 Oct;18(5):341-51
references.pmid: 17854721
references.citation: MMWR Recomm Rep. 1991 Apr 19;40(RR-4):1-17
references.pmid: 1850496
references.citation: West J Med. 1999 Mar;170(3):156-60
references.pmid: 10214102
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):998-1002
references.pmid: 16142665
references.citation: J Clin Gastroenterol. 2005 Feb;39(2):144-51
references.pmid: 15681912
references.citation: Dig Dis Sci. 1994 Oct;39(10):2250-4
references.pmid: 7924751
references.citation: J Clin Gastroenterol. 2007 Feb;41(2):185-93
references.pmid: 17245218
references.citation: J Urban Health. 2003 Dec;80(4 Suppl 3):iii7-14
references.pmid: 14713667
references.citation: Am J Public Health. 2003 May;93(5):759-63
references.pmid: 12721138
references.citation: Am J Public Health. 2002 Nov;92(11):1789-94
references.pmid: 12406810
references.citation: Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):673-6
references.pmid: 7694850
references.citation: J Infect Dis. 2005 Feb 1;191 Suppl 1:S55-60
references.pmid: 15627231
references.citation: Am J Med. 1999 Dec 27;107(6B):100S-103S
references.pmid: 10653468
references.citation: J Urban Health. 2004 Mar;81(1):25-37
references.pmid: 15047781
references.citation: Am J Public Health. 1996 May;86(5):655-61
references.pmid: 8629715
references.citation: Eur J Epidemiol. 1993 Sep;9(5):566-9
references.pmid: 8307145